1. Home
  2. FTFT vs ACET Comparison

FTFT vs ACET Comparison

Compare FTFT & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Future FinTech Group Inc.

FTFT

Future FinTech Group Inc.

N/A

Current Price

$3.65

Market Cap

26.0M

ML Signal

N/A

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

N/A

Current Price

$3.02

Market Cap

28.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FTFT
ACET
Founded
N/A
1947
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.0M
28.0M
IPO Year
2008
2017

Fundamental Metrics

Financial Performance
Metric
FTFT
ACET
Price
$3.65
$3.02
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $29.00
AVG Volume (30 Days)
★ 912.7K
209.7K
Earning Date
11-24-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $3,829,805.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 77.46
N/A
52 Week Low
$0.55
$0.46
52 Week High
$90.87
$9.97

Technical Indicators

Market Signals
Indicator
FTFT
ACET
Relative Strength Index (RSI) 56.28 21.44
Support Level $3.04 N/A
Resistance Level $3.64 $9.51
Average True Range (ATR) 0.58 0.26
MACD 0.13 0.08
Stochastic Oscillator 80.48 13.64

Price Performance

Historical Comparison
FTFT
ACET

About FTFT Future FinTech Group Inc.

Future FinTech Group Inc is engaged in the production and sale of fruit juice concentrates (including fruit purees and fruit juices), fruit beverages (including fruit juice beverages and fruit cider beverages) in the PRC. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The Company classified its business segments into Trading Commission and Consulting services, Fast-Moving Consumer Goods (FMCG), and Supply Chain Financing and Trading.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).

Share on Social Networks: